NYSE:NUS

Nu Skin Enterprises Stock Forecast, Price & News

$57.09
-1.53 (-2.61 %)
(As of 06/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$56.60
$58.51
50-Day Range
$51.78
$62.44
52-Week Range
$36.38
$63.85
Volume468,659 shs
Average Volume489,974 shs
Market Capitalization$2.86 billion
P/E Ratio13.59
Dividend Yield2.59%
Beta1.17
30 days | 90 days | 365 days | Advanced Chart
Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.


Nu Skin Enterprises logo

About Nu Skin Enterprises

Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.93 out of 5 stars

Consumer Staples Sector

40th out of 312 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 14 stocks

Analyst Opinion: 1.1Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

Is Nu Skin Enterprises a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last twelve months. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Nu Skin Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View analyst ratings for Nu Skin Enterprises
or view top-rated stocks.

What stocks does MarketBeat like better than Nu Skin Enterprises?

Wall Street analysts have given Nu Skin Enterprises a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Nu Skin Enterprises wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Nu Skin Enterprises
.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its earnings results on Wednesday, May, 5th. The company reported $0.91 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.72 by $0.19. The business earned $677.03 million during the quarter, compared to analyst estimates of $633.26 million. Nu Skin Enterprises had a trailing twelve-month return on equity of 25.88% and a net margin of 7.99%.
View Nu Skin Enterprises' earnings history
.

How has Nu Skin Enterprises' stock price been impacted by COVID-19 (Coronavirus)?

Nu Skin Enterprises' stock was trading at $21.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NUS shares have increased by 171.1% and is now trading at $57.09.
View which stocks have been most impacted by COVID-19
.

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Thursday, May 6th. Stockholders of record on Friday, May 28th will be paid a dividend of $0.38 per share on Wednesday, June 9th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 2.66%. The ex-dividend date is Thursday, May 27th.
View Nu Skin Enterprises' dividend history
.

Is Nu Skin Enterprises a good dividend stock?

Nu Skin Enterprises pays an annual dividend of $1.52 per share and currently has a dividend yield of 2.59%. Nu Skin Enterprises does not yet have a strong track record of dividend growth. The dividend payout ratio of Nu Skin Enterprises is 41.87%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 34.00% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.
View Nu Skin Enterprises' dividend history.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises updated its FY 2021 earnings guidance on Wednesday, May, 26th. The company provided earnings per share guidance of 4.050-4.300 for the period, compared to the Thomson Reuters consensus estimate of $3.990. The company issued revenue guidance of $2.80 billion-$2.87 billion, compared to the consensus revenue estimate of $2.78 billion.

What price target have analysts set for NUS?

6 brokerages have issued 12-month target prices for Nu Skin Enterprises' shares. Their forecasts range from $41.00 to $66.00. On average, they expect Nu Skin Enterprises' stock price to reach $57.00 in the next year. This suggests that the stock has a possible downside of 0.2%.
View analysts' price targets for Nu Skin Enterprises
or view top-rated stocks among Wall Street analysts.

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the following people:
  • Mr. Steven J. Lund, Exec. Chairman (Age 68, Pay $1.16M)
  • Mr. Ritch N. Wood, Chief Exec. Officer (Age 55, Pay $2.89M)
  • Mr. Ryan S. Napierski, Pres & Director (Age 47, Pay $1.99M)
  • Mr. Mark H. Lawrence, Exec. VP & CFO (Age 51, Pay $1.23M)
  • Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 68, Pay $1.59M)
  • Mr. D. Matthew Dorny, Exec. VP, Gen. Counsel & Sec. (Age 57, Pay $1.19M)
  • Mr. Blake M. Roney, Founder (Age 62)
  • Ms. Sandra N. Tillotson, Founder (Age 64)
  • Mr. Chris Stubbs, Sr. VP of Global Sales & Operations
  • Mr. James D. Thomas, Chief Accounting Officer (Age 43)

What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises CEO Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among Nu Skin Enterprises' employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Nu Skin Enterprises' key competitors?

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.33%), Renaissance Technologies LLC (5.29%), Dimensional Fund Advisors LP (3.78%), AQR Capital Management LLC (2.27%), Bank of New York Mellon Corp (1.67%) and Northern Trust Corp (1.64%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Foulis Greg, James D Thomas, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski and Steven Lund.
View institutional ownership trends for Nu Skin Enterprises
.

Which major investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Nuveen Asset Management LLC, D. E. Shaw & Co. Inc., Allianz Asset Management GmbH, Arrowstreet Capital Limited Partnership, Dimensional Fund Advisors LP, Landscape Capital Management L.L.C., and Renaissance Technologies LLC. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, James D Thomas, Joseph Y Chang, Mark H Lawrence, and Ryan S Napierski.
View insider buying and selling activity for Nu Skin Enterprises
or view top insider-selling stocks.

Which major investors are buying Nu Skin Enterprises stock?

NUS stock was purchased by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., AQR Capital Management LLC, LSV Asset Management, Northern Trust Corp, Morgan Stanley, Millennium Management LLC, Acadian Asset Management LLC, and Foundry Partners LLC. Company insiders that have bought Nu Skin Enterprises stock in the last two years include Ritch N Wood, and Steven Lund.
View insider buying and selling activity for Nu Skin Enterprises
or or view top insider-buying stocks.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $57.09.

How much money does Nu Skin Enterprises make?

Nu Skin Enterprises has a market capitalization of $2.86 billion and generates $2.58 billion in revenue each year. The company earns $191.35 million in net income (profit) each year or $3.63 on an earnings per share basis.

How many employees does Nu Skin Enterprises have?

Nu Skin Enterprises employs 5,000 workers across the globe.

What is Nu Skin Enterprises' official website?

The official website for Nu Skin Enterprises is www.nuskinenterprises.com.

Where are Nu Skin Enterprises' headquarters?

Nu Skin Enterprises is headquartered at 75 WEST CENTER ST, PROVO UT, 84601.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]


This page was last updated on 6/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.